• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KPNA2 在非小细胞肺癌中的下调与 Oct4 表达有关。

Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression.

机构信息

Department of Pathology, the First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, Shenyang 110001, China.

出版信息

J Transl Med. 2013 Sep 26;11:232. doi: 10.1186/1479-5876-11-232.

DOI:10.1186/1479-5876-11-232
PMID:24070213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3849263/
Abstract

BACKGROUND

Oct4 is a major transcription factor related to stem cell self-renewal and differentiation. To fulfill its functions, it must be able to enter the nucleus and remain there to affect transcription. KPNA2, a member of the karyopherin family, plays a central role in nucleocytoplasmic transport. The objective of the current study was to examine the association between Oct4 and KPNA2 expression levels with regard to both the clinicopathological characteristics and prognoses of patients with non-small-cell lung cancer (NSCLC).

METHODS

Immunohistochemistry was used to detect the expression profile of Oct4 and KPNA2 in NSCLC tissues and adjacent noncancerous lung tissues. Real-time polymerase chain reaction and western blotting were used to detect the mRNA and protein expression profiles of Oct4 and KPNA2 in lung cancer cell lines. Small interfering RNAs were used to deplete Oct4 and KPNA2 expressions. Double immunofluorescence was used to detect Oct4 expression in KPNA2 knockdown cells. Co-immunoprecipitation was used to detect the interaction of Oct4 and KPNA2.

RESULTS

Oct4 was overexpressed in 29 of 102 (28.4%) human lung cancer samples and correlated with differentiation (P = 0.002) and TNM stage (P = 0.003). KPNA2 was overexpressed in 56 of 102 (54.9%) human lung cancer samples and correlated with histology (P = 0.001) and differentiation (P = 0.045). Importantly, Oct4 and KPNA2 expression levels correlated significantly (P < 0.01). Expression of Oct4 and KPNA2 was associated with short overall survival. In addition, depleting Oct4 and KPNA2 expression using small interfering RNAs inhibited proliferation in lung cancer cell lines. Real-time polymerase chain reaction and western blotting analysis indicated that reduction of KPNA2 expression significantly reduced mRNA and nucleoprotein levels of Oct4. Double immunofluorescence analysis revealed that nuclear Oct4 signals were reduced significantly in KPNA2 knockdown cells. Co-immunoprecipitation experiments revealed that KPNA2 interacts with Oct4 in lung cancer cell lines.

CONCLUSION

Oct4 and KPNA2 play an important role in NSCLC progression. Oct4 nuclear localization may be mediated by its interaction with KPNA2.

摘要

背景

Oct4 是一种与干细胞自我更新和分化相关的主要转录因子。为了发挥其功能,它必须能够进入细胞核并保持在那里以影响转录。KPNA2 是核孔蛋白家族的成员,在核质转运中起着核心作用。本研究的目的是研究 Oct4 和 KPNA2 表达水平与非小细胞肺癌 (NSCLC) 患者的临床病理特征和预后之间的关系。

方法

采用免疫组织化学法检测 NSCLC 组织及相邻非癌肺组织中 Oct4 和 KPNA2 的表达谱。实时聚合酶链反应和 Western blot 检测肺癌细胞系中 Oct4 和 KPNA2 的 mRNA 和蛋白表达谱。用小干扰 RNA 耗竭 Oct4 和 KPNA2 的表达。双免疫荧光法检测 KPNA2 敲低细胞中 Oct4 的表达。免疫共沉淀检测 Oct4 和 KPNA2 的相互作用。

结果

在 102 例人肺癌样本中,有 29 例(28.4%)Oct4 过度表达,且与分化(P=0.002)和 TNM 分期(P=0.003)相关。在 102 例人肺癌样本中,有 56 例(54.9%)KPNA2 过度表达,且与组织学(P=0.001)和分化(P=0.045)相关。重要的是,Oct4 和 KPNA2 的表达水平呈显著相关(P<0.01)。Oct4 和 KPNA2 的表达与总生存期短有关。此外,用小干扰 RNA 耗竭 Oct4 和 KPNA2 的表达抑制了肺癌细胞系的增殖。实时聚合酶链反应和 Western blot 分析表明,KPNA2 表达的降低显著降低了 Oct4 的 mRNA 和核蛋白水平。双免疫荧光分析显示,KPNA2 敲低细胞中核 Oct4 信号显著减少。免疫共沉淀实验表明,KPNA2 与肺癌细胞系中的 Oct4 相互作用。

结论

Oct4 和 KPNA2 在 NSCLC 进展中起重要作用。Oct4 的核定位可能是通过其与 KPNA2 的相互作用介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/bcc1d6804af5/1479-5876-11-232-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/e6656ab9372d/1479-5876-11-232-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/42a379f886e1/1479-5876-11-232-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/b08df68c9b22/1479-5876-11-232-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/bcc1d6804af5/1479-5876-11-232-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/e6656ab9372d/1479-5876-11-232-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/42a379f886e1/1479-5876-11-232-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/b08df68c9b22/1479-5876-11-232-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62bf/3849263/bcc1d6804af5/1479-5876-11-232-4.jpg

相似文献

1
Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression.KPNA2 在非小细胞肺癌中的下调与 Oct4 表达有关。
J Transl Med. 2013 Sep 26;11:232. doi: 10.1186/1479-5876-11-232.
2
Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.KPNA2的异常表达与膀胱癌预后不良相关,并促进OCT4的核转运。
Oncotarget. 2016 Nov 8;7(45):72767-72776. doi: 10.18632/oncotarget.11889.
3
Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.定量蛋白质组学揭示了核孔蛋白亚单位 alpha-2(KPNA2)及其潜在的新型货物蛋白在非小细胞肺癌中的调控作用。
Mol Cell Proteomics. 2012 Nov;11(11):1105-22. doi: 10.1074/mcp.M111.016592. Epub 2012 Jul 25.
4
Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.核转运蛋白α2是一种新型的结肠癌预后标志物和潜在治疗靶点。
J Exp Clin Cancer Res. 2015 Dec 1;34:145. doi: 10.1186/s13046-015-0261-3.
5
MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.微小RNA-26b/核转运蛋白α2轴通过下调八聚体结合转录因子4抑制上皮性卵巢癌的增殖和转移。
Oncotarget. 2015 Sep 15;6(27):23793-806. doi: 10.18632/oncotarget.4363.
6
Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.核内 KPNA2 的聚集通过正向调控肺腺癌中的 PLSCR1-STAT1 环来影响放射抵抗。
Cancer Sci. 2022 Jan;113(1):205-220. doi: 10.1111/cas.15197. Epub 2021 Nov 25.
7
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.整合癌细胞分泌组和组织转录组鉴定核输入蛋白亚基α-2 为非小细胞肺癌的潜在生物标志物。
Int J Cancer. 2011 May 15;128(10):2364-72. doi: 10.1002/ijc.25568.
8
Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.非小细胞肺癌中假定的干性标志物八聚体结合转录因子4、性别决定区Y框蛋白2和NANOG:临床病理相关性
J Cancer Res Ther. 2020 Jul-Sep;16(4):804-810. doi: 10.4103/jcrt.JCRT_213_18.
9
mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.mTOR调节肺癌细胞中蛋白酶体降解以及Dp1/E2F1介导的KPNA2转录。
Oncotarget. 2016 May 3;7(18):25432-42. doi: 10.18632/oncotarget.8170.
10
Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.Oct4 转录调控长链非编码 RNA NEAT1 和 MALAT1 的表达,促进肺癌进展。
Mol Cancer. 2017 Jun 14;16(1):104. doi: 10.1186/s12943-017-0674-z.

引用本文的文献

1
Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma.多组学分析突出了核转运蛋白α2亚基作为儿童和成人肾上腺皮质癌预后及免疫治疗反应的一种有前景的生物标志物。
Ann Med. 2024 Dec;56(1):2397092. doi: 10.1080/07853890.2024.2397092. Epub 2024 Dec 3.
2
Integrated grade-wise profiling analysis reveals potential plasma miR-373-3p as prognostic indicator in Prostate Cancer & its target KPNA2.综合分级剖析分析揭示了血浆中潜在的miR-373-3p作为前列腺癌预后指标及其靶标KPNA2。
Noncoding RNA Res. 2024 Apr 19;9(3):954-963. doi: 10.1016/j.ncrna.2024.04.004. eCollection 2024 Sep.
3

本文引用的文献

1
Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis.在多步骤胃癌发生过程中 Oct4 的核易位的上调和抑制。
Int J Oncol. 2012 Nov;41(5):1733-43. doi: 10.3892/ijo.2012.1608. Epub 2012 Aug 24.
2
Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas.核质蛋白输入因子 a2:浸润性星形细胞瘤的新型生物标志物。
J Neurooncol. 2012 Sep;109(3):545-53. doi: 10.1007/s11060-012-0924-2. Epub 2012 Jul 7.
3
Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.
Hsa_circ_0022383 promote non-small cell lung cancer tumorigenesis through regulating the miR-495-3p/KPNA2 axis.
Hsa_circ_0022383通过调控miR-495-3p/KPNA2轴促进非小细胞肺癌的肿瘤发生。
Cancer Cell Int. 2023 Nov 19;23(1):282. doi: 10.1186/s12935-023-03068-5.
4
Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in Colorectal Adenocarcinoma and Their Response Targeting Immunotherapy.探讨结直肠腺癌中与内质网应激相关的预后标志物及其免疫治疗的反应靶点。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231212073. doi: 10.1177/15330338231212073.
5
Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis.单细胞 RNA 和 bulkRNA 分析评估的肺腺癌患者中巨噬细胞浸润的预后意义。
Front Immunol. 2022 Oct 12;13:1028440. doi: 10.3389/fimmu.2022.1028440. eCollection 2022.
6
Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.核孔蛋白α 2 和核孔蛋白β 1 的表达与胃癌的不良预后相关。
Oncology. 2022;100(12):685-695. doi: 10.1159/000526807. Epub 2022 Oct 21.
7
Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation.circ_0008812和circ_0001583的上调预示着预后不良并促进乳腺癌增殖。
Front Mol Biosci. 2022 Sep 19;9:1017036. doi: 10.3389/fmolb.2022.1017036. eCollection 2022.
8
SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer.SMARCC1通过KPNA2进入细胞核并在膀胱癌中发挥致癌作用。
Front Mol Biosci. 2022 May 20;9:902220. doi: 10.3389/fmolb.2022.902220. eCollection 2022.
9
Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.核内 KPNA2 的聚集通过正向调控肺腺癌中的 PLSCR1-STAT1 环来影响放射抵抗。
Cancer Sci. 2022 Jan;113(1):205-220. doi: 10.1111/cas.15197. Epub 2021 Nov 25.
10
Pluripotency Stemness and Cancer: More Questions than Answers.多能性 干性与癌症:问题多于答案。
Adv Exp Med Biol. 2022;1376:77-100. doi: 10.1007/5584_2021_663.
核转运受体载体蛋白-α2 促进体外恶性乳腺癌表型。
Oncogene. 2012 Apr 19;31(16):2101-14. doi: 10.1038/onc.2011.403. Epub 2011 Sep 12.
4
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy.KPNA2 表达是前列腺癌根治术后生化复发的独立不良预测因子。
Clin Cancer Res. 2011 Mar 1;17(5):1111-21. doi: 10.1158/1078-0432.CCR-10-0081. Epub 2011 Jan 10.
5
Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.下咽鳞癌中 Oct4 和 Sox2 表达的预后意义。
J Transl Med. 2010 Oct 12;8:94. doi: 10.1186/1479-5876-8-94.
6
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.整合癌细胞分泌组和组织转录组鉴定核输入蛋白亚基α-2 为非小细胞肺癌的潜在生物标志物。
Int J Cancer. 2011 May 15;128(10):2364-72. doi: 10.1002/ijc.25568.
7
Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.核输入蛋白{alpha}2(KPNA2)在食管鳞状细胞癌中的表达意义。
Anticancer Res. 2010 Mar;30(3):851-6.
8
Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.简明回顾:OCT4 的异构体导致干细胞生物学中令人困惑的多样性。
Stem Cells. 2010 May;28(5):885-93. doi: 10.1002/stem.419.
9
[OCT4 expression in hepatocellular carcinoma and its clinical significance].[OCT4在肝细胞癌中的表达及其临床意义]
Chin J Cancer. 2010 Jan;29(1):111-16. doi: 10.5732/cjc.009.10232.
10
Nucleocytoplasmic protein shuttling: the direct route in synapse-to-nucleus signaling.核质蛋白穿梭:突触到核信号的直接途径。
Trends Neurosci. 2009 Jul;32(7):392-401. doi: 10.1016/j.tins.2009.04.001. Epub 2009 Jun 11.